Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Syndrome X and microvascular coronary dysfunction.
Circulation. 2011 Sep 27;124(13):1477-80. doi: 10.1161/CIRCULATIONAHA.110.974212.
Circulation. 2011.
PMID: 21947935
Free PMC article.
No abstract available.
Effect of phosphodiesterase type 5 inhibition on microvascular coronary dysfunction in women: a Women's Ischemia Syndrome Evaluation (WISE) ancillary study.
Denardo SJ, Wen X, Handberg EM, Bairey Merz CN, Sopko GS, Cooper-Dehoff RM, Pepine CJ.
Denardo SJ, et al.
Clin Cardiol. 2011 Aug;34(8):483-7. doi: 10.1002/clc.20935. Epub 2011 Jul 21.
Clin Cardiol. 2011.
PMID: 21780138
Free PMC article.
Item in Clipboard
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia Syndrome Evaluation (WISE).
Pauly DF, Johnson BD, Anderson RD, Handberg EM, Smith KM, Cooper-DeHoff RM, Sopko G, Sharaf BM, Kelsey SF, Merz CN, Pepine CJ.
Pauly DF, et al.
Am Heart J. 2011 Oct;162(4):678-84. doi: 10.1016/j.ahj.2011.07.011. Epub 2011 Sep 6.
Am Heart J. 2011.
PMID: 21982660
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite